Please provide your email address to receive an email when new articles are posted on . A cost analysis of findings from the COLCOT trial showed that the addition of low-dose colchicine therapy to ...

Please provide your email address to receive an email when new articles are posted on . In the research summary written on behalf of the LoDoCo2 Steering Committee, researchers said the self-assembly ...

Depending on one’s perspective, the anti-inflammatory colchicine is either an unsung and underprescribed drug for patients with cardiovascular disease, or it’s an agent with limited clinical benefit ...

BASEL, SWITZERLAND — The anti-inflammatory agent colchicine failed to show significant benefit in the treatment of patients with non-cardioembolic ischemic stroke in the primary analysis of the ...